A detailed history of Kennedy Capital Management, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Kennedy Capital Management, Inc. holds 35,340 shares of LLY stock, worth $27.8 Million. This represents 0.73% of its overall portfolio holdings.

Number of Shares
35,340
Previous 32,010 10.4%
Holding current value
$27.8 Million
Previous $29 Million 8.03%
% of portfolio
0.73%
Previous 0.67%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $2.57 Million - $3.2 Million
3,330 Added 10.4%
35,340 $31.3 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $7.01 Million - $8.79 Million
9,666 Added 43.26%
32,010 $29 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $13.2 Million - $17.7 Million
22,344 New
22,344 $17.4 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $747B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.